#LCSM Chat Topic 4/2/2020: #COVID19 and #LungCancer

It seems that the world has turned upside down.  At the time I write this, there have been almost 550,00 cases of COVID-19 confirmed in the world and over 85,000 in the US.  Here in New York City there have been over 23,000 cases and 365 deaths as of March 27th (https://coronavirus.jhu.edu/map.html). The pandemic has placed enormous stress on our health care delivery system.  For lung cancer patients, it has affected healthcare providers’ ability to perform tests and radiologic procedures; provide timely diagnosis, staging, and care for early stage patients; and, in… Read More

#LCSM Chat Topic 3/5/2020: Expanding Access to Cancer Clinical Trials

Cancer research is necessary if we are to find more durable treatments for all cancers. While research has come a long way, we still have a long way to go in order to establish quality, durable treatments for many diagnosed with advanced/metastatic disease.  Typically research begins, “at the bench” with cell lines and in organoids. Once an idea has shown some promise, it often moves on to testing in animals. When an idea, test or therapeutic shows significant promise, it must move to clinical trials. Clinical trials, allow diagnostic tests, screening methods,… Read More

#LCSM Chat 2020-01-09: Ways to support #lungcancer patients and caregivers

  Our first #LCSM Chat of 2020 will focus on ways to support lung cancer patients and caregivers. A lung cancer diagnosis can be overwhelming for both patients and those who love them.  During diagnosis, the family schedule is disrupted by a myraid of doctors appointments and tests. The array of treatment options, newer therapies, and clinical trials is confusing. Once treatment begins, side effects and medical appointments may crowd out normal routine and make cancer the focus of everything.  If the cancer returns or progresses, the cycle begins again. If the… Read More